ITOC shows whipsaw volatility in both price and short positioning. The stock jumped 25% in one day to $0.374, while short interest surged 2,693% month-over-month from minimal levels. Cost to borrow fell sharply to 134%, down from 260% a month ago, as utilisation dropped to just 6% — well below the 52-week high of 100%.
ITOC closed at $0.374 on April 24, up 25% on the day. The week brought a 18% gain, extending the monthly rally to 31%. The health-care technology name has seen extreme volatility since late March, when the stock emerged from near-dormant status.
Short interest stands at 100,807 shares as of April 23. The absolute share count is modest, but the month-over-month jump is dramatic — short shares multiplied 28-fold from the 3,609-share level recorded in mid-March. Over the past week, short interest climbed 16%.
The spike appears to track the late-March surge in trading activity. Short shares peaked at 959,408 on March 25, then declined steadily through early April. By April 17, the count had fallen to 82,895 before climbing back above 100,000 in recent days.
Cost to borrow has retreated sharply. The current 134% APR is down 39% week-over-week and 47% below the 260% peak hit on April 3. The mid-March dormant period saw CTB as low as 37%, then readings spiked into the 220–260% range through early April.
Utilisation sat at 6.26% on April 23, down from 8.28% a week earlier. The reading is far below the March 25 peak of 91% and the 52-week high of 100%. The decline suggests abundant borrow supply relative to demand — consistent with the CTB drop.
Days to cover remains at 1.0 according to the most recent FINRA fortnightly report (settlement April 15), which recorded 159,717 shares short.
ITOC ranks in the 31st percentile for short score (43.9 out of 100). The score has oscillated between 43 and 49 over the past two weeks, reflecting the shifting short-interest landscape.
The stock scores in the 79th percentile for sector positioning. Days to cover ranks in the 90th percentile, indicating a relatively high reading versus peers, while utilisation sits at the 55th percentile. Dividend score is in the 28th percentile.
Chairman Jianfei Zhang holds 7.67 million shares — 45% of the company — with no change at last report (December 31, 2024). Two other large individual holders, Ho Way (972,000 shares, 5.7%) and Asep Priharyanto (960,000 shares, 5.6%), held steady as of early April 2025.
UBS Asset Management trimmed its position by 196,302 shares to 108,000 (0.63%) in Q4 2025. XTX Markets added 33,427 shares to reach 82,835 (0.49%).
Citadel Advisors initiated a 13,049-share position (0.08%) in Q4, as did Two Sigma Investments with 10,888 shares (0.06%) and Two Sigma Securities with 15,773 shares (0.09%). Point72 Asset Management held 10,852 shares (0.06%) unchanged.
iTonic announced earnings events on March 30, 2026 and April 2, 2026. Earlier prints occurred in December 2025 and March 2025. The snapshot contains no reaction data for these events.
The extreme short-interest fluctuation from near-zero in mid-March to 959,000 shares on March 25 aligns with a broader surge in trading volume and volatility. Short sellers appear to have covered aggressively through early April, reducing the position by two-thirds before rebuilding modestly in recent sessions.
No upcoming earnings date is scheduled. Monitor whether short interest stabilises near current levels or resumes the volatile swings seen in late March. The plunge in cost to borrow and utilisation suggests the stock has become easier to short, potentially inviting fresh bearish positioning if the recent price rally stalls.
See the live data behind this article on ORTEX.
Open ITOC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
